DOGLIOTTI, Luigi
 Distribuzione geografica
Continente #
NA - Nord America 498
EU - Europa 208
AS - Asia 133
Continente sconosciuto - Info sul continente non disponibili 1
Totale 840
Nazione #
US - Stati Uniti d'America 498
CN - Cina 79
DE - Germania 76
UA - Ucraina 75
SG - Singapore 28
HK - Hong Kong 18
GB - Regno Unito 16
RU - Federazione Russa 15
IE - Irlanda 10
TR - Turchia 8
FI - Finlandia 7
CZ - Repubblica Ceca 3
IT - Italia 3
FR - Francia 2
CH - Svizzera 1
EU - Europa 1
Totale 840
Città #
Ann Arbor 58
Woodbridge 57
Fairfield 56
Jacksonville 55
Houston 41
Nanjing 26
Singapore 24
Cambridge 23
Wilmington 23
Ashburn 22
Princeton 22
Chandler 21
Seattle 19
Hong Kong 18
Dearborn 15
New York 13
Beijing 12
Dublin 10
Shanghai 9
Istanbul 7
Helsinki 6
San Diego 5
San Francisco 5
Changsha 4
Tianjin 4
Brno 3
Des Moines 3
Jiaxing 3
Nanchang 3
Nürnberg 3
Hangzhou 2
Hebei 2
Jinan 2
Kunming 2
Lanzhou 2
Marietta 2
Orange 2
Shenyang 2
Augusta 1
Changchun 1
Guangzhou 1
Hefei 1
Lancaster 1
New Bedfont 1
Paris 1
Prescot 1
Taizhou 1
Verano Brianza 1
Verona 1
Walnut 1
Wuhan 1
Totale 599
Nome #
Anti-Angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients 117
International expert consensus on primary systemic therapy in the management of early breast cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013) 109
Thymidylate synthase expression in gastroenteropancreatic and pulmonary neuroendocrine tumors 94
Phosphorylated ERα, HIF-1α, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer 91
The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen 86
Continuous 5-fluorouracil infusion plus long acting octreotide in advanced well-differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte Oncology Network 84
Sorafenib may induce hypophosphatemia through a fibroblast growth factor-23 (fGF23)-independent mechanism 79
Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma (multiple letter) [2] 56
The prognostic role of immunohistochemical chromogranin A expressionin prostate cancer patients is significantly modified by androgen-deprivation therapy 52
Corrigendum to "Gene expression profiling in breast cancer: A clinical perspective" [The Breast 22 (2013) 109-120 [doi:10.1016/j.breast.2013.01.016.]] 47
LHRH analogs in treatment of metastatic breast carcinoma 46
Totale 861
Categoria #
all - tutte 4.619
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.619


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020169 0 0 0 0 14 34 28 28 17 25 9 14
2020/2021121 2 16 1 14 4 14 3 15 18 18 15 1
2021/202284 5 26 2 2 2 0 7 8 6 3 3 20
2022/202365 11 0 1 1 1 19 0 14 10 0 4 4
2023/202477 6 2 9 2 5 13 2 5 18 0 2 13
2024/202539 0 0 1 23 15 0 0 0 0 0 0 0
Totale 861